The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery

Lola Elizabeth Lawuyi, Avinash Gurbaxani Moorfields Eye Hospital Dubai, Dubai, UAE Abstract: The maintenance of mydriasis throughout cataract extraction surgery and the control of ocular inflammation are crucial for successful surgical outcomes. The development of miosis during cataract surgery co...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lawuyi LE, Gurbaxani A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/08cccd6c63144f409cb13d41c781902d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:08cccd6c63144f409cb13d41c781902d
record_format	dspace
spelling	oai:doaj.org-article:08cccd6c63144f409cb13d41c781902d2021-12-02T00:24:50ZThe clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery1177-5483https://doaj.org/article/08cccd6c63144f409cb13d41c781902d2015-07-01T00:00:00Zhttp://www.dovepress.com/the-clinical-utility-of-new-combination-phenylephrineketorolac-injecti-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Lola Elizabeth Lawuyi, Avinash Gurbaxani Moorfields Eye Hospital Dubai, Dubai, UAE Abstract: The maintenance of mydriasis throughout cataract extraction surgery and the control of ocular inflammation are crucial for successful surgical outcomes. The development of miosis during cataract surgery compromises the visualization of the surgical field and working space for surgeons. This may lead to complications that include posterior capsular tear and associated vitreous loss, longer surgical time, and postoperative inflammation. Postoperative inflammation is often uncomfortable and frustrating for patients. It causes pain, redness, and photophobia. This compromises the best-uncorrected vision following surgery and often leads to multiple clinic visits. This article examines the literature published on the current treatments used to manage mydriasis, pain, and inflammation in cataract extraction surgery. Combination phenylephrine/ketorolac injection offers an exciting new class of medication for use in cataract surgery. With the recent approval of Omidria™ (combination of phenylephrine 1% and ketorolac 0.3%) by the US Food and Drug Administration (FDA) for intraocular use, we review the clinical utility of this new combination injection in cataract surgery. PubMed, MEDLINE, and conference proceedings were searched for the relevant literature using a combination of the following search terms: cataract extraction surgery, pupil dilation (mydriasis), miosis, phenylephrine, ketorolac, Omidria™, intracameral mydriatic. Relevant articles were reviewed and their references checked for further relevant literature. All abstracts were reviewed and full texts retrieved where available. Keywords: cataract extraction surgery, ketorolac, mydriasis, miosis, Omidria™, phenylephrineLawuyi LEGurbaxani ADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 1249-1254 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Lawuyi LE Gurbaxani A The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
description	Lola Elizabeth Lawuyi, Avinash Gurbaxani Moorfields Eye Hospital Dubai, Dubai, UAE Abstract: The maintenance of mydriasis throughout cataract extraction surgery and the control of ocular inflammation are crucial for successful surgical outcomes. The development of miosis during cataract surgery compromises the visualization of the surgical field and working space for surgeons. This may lead to complications that include posterior capsular tear and associated vitreous loss, longer surgical time, and postoperative inflammation. Postoperative inflammation is often uncomfortable and frustrating for patients. It causes pain, redness, and photophobia. This compromises the best-uncorrected vision following surgery and often leads to multiple clinic visits. This article examines the literature published on the current treatments used to manage mydriasis, pain, and inflammation in cataract extraction surgery. Combination phenylephrine/ketorolac injection offers an exciting new class of medication for use in cataract surgery. With the recent approval of Omidria™ (combination of phenylephrine 1% and ketorolac 0.3%) by the US Food and Drug Administration (FDA) for intraocular use, we review the clinical utility of this new combination injection in cataract surgery. PubMed, MEDLINE, and conference proceedings were searched for the relevant literature using a combination of the following search terms: cataract extraction surgery, pupil dilation (mydriasis), miosis, phenylephrine, ketorolac, Omidria™, intracameral mydriatic. Relevant articles were reviewed and their references checked for further relevant literature. All abstracts were reviewed and full texts retrieved where available. Keywords: cataract extraction surgery, ketorolac, mydriasis, miosis, Omidria™, phenylephrine
format	article
author	Lawuyi LE Gurbaxani A
author_facet	Lawuyi LE Gurbaxani A
author_sort	Lawuyi LE
title	The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
title_short	The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
title_full	The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
title_fullStr	The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
title_full_unstemmed	The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
title_sort	clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/08cccd6c63144f409cb13d41c781902d
work_keys_str_mv	AT lawuyile theclinicalutilityofnewcombinationphenylephrineketorolacinjectionincataractsurgery AT gurbaxania theclinicalutilityofnewcombinationphenylephrineketorolacinjectionincataractsurgery AT lawuyile clinicalutilityofnewcombinationphenylephrineketorolacinjectionincataractsurgery AT gurbaxania clinicalutilityofnewcombinationphenylephrineketorolacinjectionincataractsurgery
_version_	1718403721042329600

The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery

Ejemplares similares